Pacemakers Market Size, Statistics, Trend Analysis and Forecast Report, 2020 - 2027

By Product (Implantable Pacemakers, External Pacemakers), By Technology (Single-chamber Pacemakers {Single-chamber Atrial, Single-chamber Ventricular}, Dual-chamber Pacemakers, Biventricular/CRT Pacemakers), By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Application (Congestive Heart Failure, Arrhythmias, Bradycardia, Tachycardia), By Age (Under 22 years, 23 – 49 years, 50 – 64 years, 65+ years), By End-use (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Poland, Russia, China, Japan, India, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE)
 

  • Report ID : MD1445
  • |
  • Pages : 240
  • |
  • Tables : 85
  • |
  • Formats :

Pacemakers Market size was estimated at $3,176.6 Million in 2019 and is expected to reach $3,880.3 Million by 2027, growing at a CAGR of 2.9% during the forecast period of 2020 to 2027.

pacemakers market
A Pacemaker is a small electric device which is fitted in the chest or the abdomen. It keeps a check on when the heart beats too much or starts to miss beats. They are fitted by highly specialized medical professions with the use of anesthesia.
 
Analysis by Product
According to products, the two segments are Implantable and External Pacemakers.
Implantable pacemakers are the most popular type among the two. It is a multi-million dollar market size. It helps in the overall lifecycle of the product while it serves patients. The lion’s share of the market is taken up by Implantable pacemakers. They are non-obtrusive and allows the users to function in their normal life with ease. These products also keep a close tab on the functioning of the heart.
 
Analysis by Technology
According to technology, the three major segments are Single Chamber, Dual Chamber, and Bi-ventricular pacemakers. The last one is also referred to as CRT pacemakers.
Single Chamber pacemakers connects to one chamber of the heart. For most patients, this is the preferred type of pacemaker. It is connected to the upper heart chamber for stimulation.
Dual Chamber pacemakers have two leads and thus it connects to both sides on the right of the heart. The medical professional programs the said pacemaker to regulate both chambers. The application of these types of pacemakers is specific to situations. The Dual Chamber pacemakers market is likely to grow tremendously in the forecasted period.
 
Analysis by Type
Two broad segments by type are those that are MRI compatible and the conventional ones.
MRI compatible pacemakers are all set for double-digit growth rates. A lot of cases with the requirement of magnetic resonance imaging are surfacing and MRI compatible pacemakers fulfill that requirement very well.
A large portion of patients are already using implantable medical devices with magnetic resource imaging. Additionally, the medical professional community has begun to provide MRI with cardiac pacemakers. This is a big boost for the product sales in the future.
 
Analysis by Application
The application types are segmented into the following: Congestive Heart Failure, Arrhythmias, Bradycardia, and Tachycardia.
 
Application in cases of Tachycardia will show the highest growth in the forecasted period. Aging population and a rising trend of atrial flutter will be the largest growth drivers. Moreover, changing lifestyles are also resulting in hypertension. That is another reason for its high anticipated growth.
 
Analysis by Age
According to age, the segments are Under 22 years, 23 – 49 years, 50 – 64 years, 65+ years.
Of these, it is the last segment (65+ years) that will contribute the most to the market. This is because all the issues highlighted before are more prone in this age group.
 
Analysis by End-use
According to End-use, the segments are Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers, and Clinics.
Cardiac Care Centers will demonstrate the highest segmental growth. This is because of their large spread consumer reach. They are also usually run by very experienced cardiologists. 
 
Analysis by Region 
The United States of America is the largest consumer of this product. Government approvals, better access to medical infrastructure and a large customer base are the reasons behind this growth.
 
Analysis by Market
Important players in the market are Boston Scientific, Medtronic, and Biotronik. Mergers and Acquisitions are likely to be on the cards as the players try to leverage their strategic hold on a sumptuous market.
 
COVERAGE HIGHLIGHTS    
●   Market Revenue Estimation and Forecast (2019 – 2026)
●   Market Production Estimation and Forecast (2019 – 2026)
●   Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
●   Breakdown of Revenue by Segments (2019 – 2026)
●   Breakdown of Production by Segments (2019 – 2026)
●   Breakdown of Sales Volume by Segments (2019 – 2026)
●   Gross Margin and Profitability Analysis of Companies
●   Business Trend and Expansion Analysis
●   Import and Export Analysis
●   Regional Analysis and Market Data Breakdown
 

MARKET SEGMENTATION
 
By ProductOutlook ($Revenue and Unit Sales, 2019-2026)
•    Implantable Pacemakers
•    External Pacemakers
By TechnologyOutlook ($Revenue and Unit Sales, 2019-2026)
•    Single-chamber Pacemakers
o    Single-chamber Atrial
o    Single-chamber Ventricular
•    Dual-chamber Pacemakers
•    Biventricular/CRT Pacemakers
By TypeOutlook ($Revenue and Unit Sales, 2019-2026)
•    MRI Compatible Pacemakers
•    Conventional Pacemakers
By ApplicationOutlook ($Revenue and Unit Sales, 2019-2026)
•    Congestive Heart Failure
•    Arrhythmias
•    Bradycardia
•    Tachycardia
By AgeOutlook ($Revenue and Unit Sales, 2019-2026)
•    Under 22 years
•    23 - 49 years
•    50 - 64 years
•    65+ years
By End-useOutlook ($Revenue and Unit Sales, 2019-2026)
•    Hospitals
•    Cardiac Care Centers
•    Ambulatory Surgical Centers
•    Clinics
•    Others

By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
•    North America
o    U.S.
o    Canada
•    Europe
o    Germany
o    UK
o    France
o    Spain
o    Italy
o    Russia
o    Poland
•    Asia Pacific
o    China
o    Japan
o    India
o    Australia
o    South Korea
o    Taiwan
•    Latin America
o    Brazil
o    Mexico
o    Argentina
•    Middle East & Africa
o    South Africa
o    Saudi Arabia
o    UAE

Market Players
•    Medtronic
•    Boston Scientific Corporation
•    Abbott
•    BIOTRONIK
•    Lepu Medical
•    Sorin
•    OSCOR Inc.
•    Pacetronix
•    Osypka Medical
•    Microport Scientific Corporation

 

CHAPTER 1:    INTRODUCTION
 

1.1.    RESEARCH METHODOLOGY
1.1.1.    Desk Research 
1.1.2.    Data Synthesis 
1.1.3.    Data Validation & Market Feedback 
1.1.4.    Data Sources 

 

CHAPTER 2:    EXECUTIVE SUMMARY
2.1.    GLOBAL MARKET OUTLOOK
2.2.    CORE INSIGHTS –DELIVERY MODEL
2.3.    CORE INSIGHTS – PACEMAKERS 
2.4.    CORE INSIGHTS – SERVICE PROVIDER
2.5.    CORE INSIGHTS – GEOGRAPHY
 

 

CHAPTER 3:   MARKET OVERVIEW
 

3.1.     MARKET DEFINITION AND SCOPE
 

3.2.    KEY FORCES SHAPING THE INDUSTRY
3.2.1.    Bargaining Power of Suppliers
3.2.2.    Bargaining Power of Buyers
3.2.3.    Threat of Substitutes
3.2.4.    Threat of New Entrants

 

3.3.    MARKET DYNAMICS
3.3.1.    Drivers
             3.3.1.1.    Supply-side Drivers
             3.3.1.2.    Demand-side Drivers
3.3.2.    Restraints
3.3.3.    Opportunities

 

3.4.    INDUSTRY - ANALYSIS
3.4.1.    Political Market
3.4.2.    Environmental Market
3.4.3.    Social Market
3.4.4.    Technology Market

 

CHAPTER 4:    MARKET BACKGROUND
 

4.1.    Industry Value Chain Analysis
4.1.1.    Upstream Participants 
4.1.2.    Downstream participants

 

4.2.    Pricing Analysis and Forecast, 2019-2026
4.2.1.    By Type
4.2.2.    By Region

 

CHAPTER 5:    PACEMAKERS MARKET, BY PRODUCT OUTLOOK
 

5.1.    Overview
5.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

5.2.    Implantable Pacemakers
5.2.1.    Key Market Trends, Growth Factors and Opportunities
5.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.3.    External Pacemakers
5.3.1.    Key Market Trends, Growth Factors and Opportunities
5.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 6:     PACEMAKERS MARKET BY TECHNOLOGY OUTLOOK
 

6.1.    Overview
6.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

6.2.    Single-chamber Pacemakers
6.2.1.    Key Market Trends, Growth Factors and Opportunities
6.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.3.    Single-chamber Atrial
6.3.1.    Key Market Trends, Growth Factors and Opportunities
6.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.4.    Single-chamber Ventricular
6.4.1.    Key Market Trends, Growth Factors and Opportunities
6.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.5.    Dual-chamber Pacemakers
6.5.1.    Key Market Trends, Growth Factors and Opportunities
6.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.6.    Biventricular/CRT Pacemakers
6.6.1.    Key Market Trends, Growth Factors and Opportunities
6.6.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 7:    PACEMAKERS MARKET BY TYPE OUTLOOK
 

7.1.    Overview
7.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

7.2.    MRI Compatible Pacemakers
7.2.1.    Key Market Trends, Growth Factors and Opportunities
7.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

7.3.    Conventional Pacemakers
7.3.1.    Key Market Trends, Growth Factors and Opportunities

 

CHAPTER 8:     PACEMAKERS MARKET BY APPLICATION OUTLOOK
 

8.1.    Overview
8.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

8.2.    Congestive Heart Failure
8.2.1.    Key Market Trends, Growth Factors and Opportunities
8.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

8.3.    Arrhythmias
8.3.1.    Key Market Trends, Growth Factors and Opportunities
8.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

8.4.    Bradycardia
8.4.1.    Key Market Trends, Growth Factors and Opportunities
8.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

8.5.    Tachycardia
8.5.1.    Key Market Trends, Growth Factors and Opportunities
8.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 9:     PACEMAKERS MARKET BY AGE OUTLOOK
 

9.1.    Overview
9.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

9.2.    Under 22 years
9.2.1.    Key Market Trends, Growth Factors and Opportunities
9.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

9.3.    23 - 49 years
9.3.1.    Key Market Trends, Growth Factors and Opportunities
9.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

9.4.    50 - 64 years
9.4.1.    Key Market Trends, Growth Factors and Opportunities
9.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

9.5.    65+ years
9.5.1.    Key Market Trends, Growth Factors and Opportunities
9.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 10:     PACEMAKERS MARKET BY END-USE OUTLOOK
 

10.1.    Overview
10.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

10.2.    Hospitals
10.2.1.    Key Market Trends, Growth Factors and Opportunities
10.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

10.3.    Cardiac Care Centers
10.3.1.    Key Market Trends, Growth Factors and Opportunities
10.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

10.4.    Ambulatory Surgical Centers
10.4.1.    Key Market Trends, Growth Factors and Opportunities
10.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

10.5.    Clinics
10.5.1.    Key Market Trends, Growth Factors and Opportunities
10.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

10.6.    Others
10.6.1.    Key Market Trends, Growth Factors and Opportunities
10.6.2.    Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 11:    PACEMAKERS MARKET, BY GEOGRAPHY
 

11.1.    Overview
11.2.    North America 
11.2.1.    Key Market Trends, Growth Factors and Opportunities
11.2.2.    Market Revenue and Forecast, By Delivery Model
11.2.3.    Market Revenue and Forecast, By Agriculture Type
11.2.4.    Market Revenue and Forecast, By Service Provider
11.2.5.    Market Revenue and Forecast, By Country
11.2.6.    U.S.
              11.2.6.1.    Market Revenue and Forecast
11.2.7.    Canada
              11.2.7.1.    Market Revenue and Forecast
11.2.8.    Mexico
              11.2.8.1.    Market Revenue and Forecast
11.3.    Europe
11.3.1.    Market Revenue and Forecast, By Delivery Model
11.3.2.    Market Revenue and Forecast, By Agriculture Type
11.3.3.    Market Revenue and Forecast, By Service Provider
11.3.4.    Market Revenue and Forecast, By Country
11.3.5.    Germany
               11.3.5.1.    Market Revenue and Forecast
11.3.6.    UK
               11.3.6.1.    Market Revenue and Forecast
11.3.7.    France
              11.3.7.1.    Market Revenue and Forecast
11.3.8.    Italy
               11.3.8.1.    Market Revenue and Forecast
11.3.9.    Spain
               11.3.9.1.    Market Revenue and Forecast
11.3.10.    Poland
               11.3.10.1.    Market Revenue and Forecast
11.3.11.    Austrai
                11.3.11.1.    Market Revenue and Forecast
11.3.12.    Luxembourg
                11.3.12.1.    Market Revenue and Forecast
11.3.13.    Rest of Europe
                11.3.13.1.    Market Revenue and Forecast

11.4.    Asia-Pacific
11.4.1.    Market Revenue and Forecast, By Delivery Model
11.4.2.    Market Revenue and Forecast, By Agriculture Type
11.4.3.    Market Revenue and Forecast, By Service Provider
11.4.4.    Market Revenue and Forecast, By Country
11.4.5.    China
              11.4.5.1.    Market Revenue and Forecast
11.4.6.    India
              11.4.6.1.    Market Revenue and Forecast
11.4.7.    Japan 
              11.4.7.1.    Market Revenue and Forecast
11.4.8.    South Korea 
              11.4.8.1.    Market Revenue and Forecast
11.4.9.    Rest of APAC
              11.4.9.1.    Market Revenue and Forecast

 

11.5.    REST OF THE WORLD
11.5.1.    Market Revenue and Forecast, By Delivery Model
11.5.2.    Market Revenue and Forecast, By Agriculture Type
11.5.3.    Market Revenue and Forecast, By Service Provider
11.5.4.    Market Revenue and Forecast, By Country
11.5.5.    Latin America 
              11.5.5.1.    Market Revenue and Forecast
11.5.6.    Middle East  
              11.5.6.1.    Market Revenue and Forecast
11.5.7.    Africa 
              11.5.7.1.    Market Revenue and Forecast

 

CHAPTER 12:  COMPANY PROFILES
 

12.1.    Airbus S.A.S
12.1.1.    Company Overview 
12.1.2.    Financial Performance
12.1.3.    SWOT Analysis

 

12.2.    Aviation Industry Corporation of China Ltd. (AVIC)
12.2.1.    Company Overview 
12.2.2.    Financial Performance
12.2.3.    SWOT Analysis

 

12.3.    Astronics Corporation
12.3.1.    Company Overview 
12.3.2.    Financial Performance
12.3.3.    SWOT Analysis

 

12.4.    Boeing
12.4.1.    Company Overview 
12.4.2.    Financial Performance
12.4.3.    SWOT Analysis

 

12.5.    Ball Corporation
12.5.1.    Company Overview 
12.5.2.    Financial Performance
12.5.3.    SWOT Analysis

 

12.6.    BAE Systems
12.6.1.    Company Overview 
12.6.2.    Financial Performance
12.6.3.    SWOT Analysis

 

12.7.    Cobham plc
12.7.1.    Company Overview 
12.7.2.    Financial Performance
12.7.3.    SWOT Analysis

 

12.8.    Curtiss Wright
12.8.1.    Company Overview 
12.8.2.    Financial Performance
12.8.3.    SWOT Analysis

 

12.9.    Elbit System
12.9.1.    Company Overview 
12.9.2.    Financial Performance
12.9.3.    SWOT Analysis

 

12.10.    Gramin Ltd
12.10.1.    Company Overview 
12.10.2.    Financial Performance
12.10.3.    SWOT Analysis

 

12.11.    GE Aviation
12.11.1.    Company Overview 
12.11.2.    Financial Performance
12.11.3.    SWOT Analysis

 

12.12.    Harris Corporation
12.12.1.    Company Overview 
12.12.2.    Financial Performance
12.12.3.    SWOT Analysis

 

12.13.    Honeywell International Inc.
12.13.1.    Company Overview 
12.13.2.    Financial Performance
12.13.3.    SWOT Analysis

 

12.14.    Lockheed Martin Corporation
12.14.1.    Company Overview 
12.14.2.    Financial Performance
12.14.3.    SWOT Analysis

 

12.15.    L3 Harris Corporation
12.15.1.    Company Overview 
12.15.2.    Financial Performance
12.15.3.    SWOT Analysis

 

12.16.    Meggitt PLC
12.16.1.    Company Overview 
12.16.2.    Financial Performance
12.16.3.    SWOT Analysis

 

12.17.    Northrop Grumman Corporation
12.17.1.    Company Overview 
12.17.2.    Financial Performance
12.17.3.    SWOT Analysis

 

12.18.    Nucon Aerospace
12.18.1.    Company Overview 
12.18.2.    Financial Performance
12.18.3.    SWOT Analysis

 

12.19.    Panasonic Corporation
12.19.1.    Company Overview 
12.19.2.    Financial Performance
12.19.3.    SWOT Analysis

 

12.20.    Rolls Royce
12.20.1.    Company Overview 
12.20.2.    Financial Performance
12.20.3.    SWOT Analysis

 

12.21.    Raytheon Company
12.21.1.    Company Overview 
12.21.2.    Financial Performance
12.21.3.    SWOT Analysis

 

12.22.    Saab AB
12.22.1.    Company Overview 
12.22.2.    Financial Performance
12.22.3.    SWOT Analysis

 

12.23.    Safran
12.23.1.    Company Overview 
12.23.2.    Financial Performance
12.23.3.    SWOT Analysis

 

12.24.    Thales Group
12.24.1.    Company Overview 
12.24.2.    Financial Performance
12.24.3.    SWOT Analysis

 

12.25.    Teledyne Technologies Inc.
12.25.1.    Company Overview 
12.25.2.    Financial Performance
12.25.3.    SWOT Analysis

 

12.26.    Transdigm Group Inc.
12.26.1.    Company Overview 
12.26.2.    Financial Performance
12.26.3.    SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com